Related Experiment Video

Updated: Nov 6, 2025

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
09:03

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic

Published on: November 7, 2020

5.1K

Pediatrics and COVID-19

Tuna Toptan1, Sandra Ciesek1, Sebastian Hoehl2

  • 1Institute of Medical Virology, University Hospital Frankfurt, Goethe University, Frankfurt, Germany.

Advances in Experimental Medicine and Biology
|May 11, 2021
PubMed

Insights

Pediatric COVID-19 is typically mild, with severe illness being rare in children. Researchers are investigating why children’s immune responses differ from adults, potentially explaining this lower severity in young individuals.

Area of Science:

  • Pediatric infectious diseases
  • Immunology
  • Virology

Background:

  • Viral respiratory infections significantly impact global childhood morbidity.
  • COVID-19 presents unique challenges in pediatric populations worldwide.

Purpose of the Study:

  • To describe preliminary characteristics of pediatric COVID-19.
  • To explore reasons for the lower severity of COVID-19 in children compared to adults.

Main Methods:

  • Review of preliminary data on pediatric COVID-19 cases.
  • Exploration of differences in pediatric versus adult immune responses.
  • Analysis of host factors, including Angiotensin-Converting Enzyme 2 (ACE2) abundance.

Main Results:

  • Severe and critical COVID-19 disease is rare in children.
  • A significant proportion of pediatric cases remain asymptomatic.
  • Age-dependent severity patterns in COVID-19 are observed but not fully understood.

Conclusions:

  • Children generally experience milder COVID-19 outcomes compared to adults.
  • Differences in immune response and host factors like ACE2 may explain the lower severity in pediatric populations.
  • Further research is needed to elucidate the mechanisms behind age-related COVID-19 severity.

Keywords:
ACE2AdolescentsCOVID-19ChildrenImmunityPediatricsSARS-CoV-2

More Related Videos

Guidelines for Elective Pediatric Fiberoptic Intubation11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

17.9K
Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

2.9K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
59
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
68
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
75
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
53
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
51
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.6K